Lung cancer screening among minority groups: Identifying gaps in screening and opportunities for intervention

The American Cancer Society projects that approximately 234,500 new cases of lung cancer will be identified in 2024, with more than one-half of these cases resulting in death.1 The United States Preventive Services Task Force (USPSTF) strongly advocates for annual lung cancer screening (LCS) using low-dose computed tomography (LDCT) for individuals age 50 to 80 years with reasonable life expectancy and a smoking history of at least 20 pack-years, whether they currently smoke or have quit within the past 15 years.